IATDMCT 2017

Presentation information

Print

Oral

[O26-3] O26-3: Pharmacogenomics (1)

Tue. Sep 26, 2017 3:00 PM - 4:00 PM Room C1 (1F)

Chairs: Ichiro Ieiri, Japan / Vincent Haufroid, Belgium

[O26-3-4] Dihydropyrimidine dehydrogenase deficiency in patients treated with 5FU or capecitabine based regimens: a tertiary care centre experience

Pavithran Keechilat1, Arun Philip2, Akhila Sivadas3, Judith Mary Hariprakash4, Aradhana A.5, Akhilesh Kumar Sonakar6, Vinod Scaria7 (1.Amrita Insitute of Medical Sciences, 2.Amrita Insitute of Medical Sciences, 3.Amrita Insitute of Medical Sciences, 4.CSIR Institute of Genomics and Integrative Biology, 5.CSIR Institute of Genomics and Integrative Biology, 6.CSIR Institute of Genomics and Integrative Biology, 7.CSIR Institute of Genomics and Integrative Biology)

Keywords:Dihydropyrimidine dehydrogenase deficiency 5FU, Capecitabine, Toxicity,

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Password